Home › Compare › HRAA vs CL

HRAA vs CL: Dividend Comparison 2026

HRAA yields 4000.00% · CL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRAA wins by $7175340620755.84M in total portfolio value
10 years
HRAA
HRAA
● Live price
4000.00%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7175340620755.87M
Annual income
$6,839,006,593,197,835,000.00
Full HRAA calculator →
CL
CL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full CL calculator →

Portfolio growth — HRAA vs CL

📍 HRAA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHRAACL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HRAA + CL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
HRAA pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRAA
Annual income on $10K today (after 15% tax)
$340,000.00/yr
After 10yr DRIP, annual income (after tax)
$5,813,155,604,218,160,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, HRAA beats the other by $5,813,155,604,218,159,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRAA + CL for your $10,000?

HRAA: 50%CL: 50%
100% CL50/50100% HRAA
Portfolio after 10yr
$3587670310377.95M
Annual income
$3,419,503,296,598,918,000.00/yr
Blended yield
95.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

HRAA
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+84.9% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRAA buys
0
CL buys
9
PoliticianChamberTickerTypeAmountDate
John Boozman🏛 Senate$CL▼ Sell$1,001 - $15,0002025-10-09
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-10-07
Rick Larsen🏢 House$CL▼ Sell$1,001 - $15,0002025-10-06
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CL▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CL▼ Sell$1,001 - $15,0002025-09-11
Tim Moore🏢 House$CL▼ Sell$1,001 - $15,0002025-09-10
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-08-26
Lisa McClain🏢 House$CL▲ Buy$1,001 - $15,0002025-08-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHRAACL
Forward yield4000.00% ✓4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5% ✓
5-year div CAGR0%5% ✓
Portfolio after 10y$7175340620755.87M ✓$28.0K
Annual income after 10y$6,839,006,593,197,835,000.00 ✓$899.19
Total dividends collected$7152397773804.84M ✓$6.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: HRAA vs CL ($10,000, DRIP)

YearHRAA PortfolioHRAA Income/yrCL PortfolioCL Income/yrGap
1← crossover$410,700$400,000.00$11,120$420.00+$399.6K → HRAA
2$15,792,720$15,353,271.03$12,357$458.31+$15.78M → HRAA
3$568,657,142$551,758,931.89$13,721$499.76+$568.64M → HRAA
4$19,176,207,860$18,567,744,718.20$15,227$544.58+$19176.19M → HRAA
5$605,696,028,890$585,177,486,479.73$16,885$593.02+$605696.01M → HRAA
6$17,922,210,653,594$17,274,115,902,681.27$18,713$645.34+$17922210.63M → HRAA
7$496,869,793,504,300$477,693,028,104,954.00$20,724$701.81+$496869793.48M → HRAA
8$12,908,672,105,251,704$12,377,021,426,202,104.00$22,938$762.73+$12908672105.23M → HRAA
9$314,330,866,876,668,540$300,518,587,724,049,200.00$25,372$828.41+$314330866876.64M → HRAA
10$7,175,340,620,755,871,000$6,839,006,593,197,835,000.00$28,047$899.19+$7175340620755.84M → HRAA

HRAA vs CL: Complete Analysis 2026

HRAA — Stock

Health Revenue Assurance Holdings, Inc. provides revenue cycle services for healthcare providers in the United States. It also offers revenue cycle data analysis, contract, and outsourced coding services; and billing, coding and compliance audits, coding education, coding consulting, physician coding, and ICD-10 education and transition services. The company was founded in 2001 and is based in New York, New York.

Full HRAA Calculator →

CL — Consumer Staples

CL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CL shares.

Full CL Calculator →
📬

Get this HRAA vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRAA vs SCHDHRAA vs JEPIHRAA vs OHRAA vs KOHRAA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.